Product Description
Detect SARS-CoV-2 and confirm sample quality in a single well. This Zymo Research multiplex real-time RT-PCR kit qualitatively identifies viral RNA with a limit of detection as low as 10 genome copies per reaction and delivers results in under two hours. The single-well design also saves reagents and plate space.
This listing is for catalog number R3013: Quick SARS-CoV-2 Multiplex Kit, 100 Rxns. The assay amplifies a region of the viral nucleocapsid gene alongside human RNase P as a specimen adequacy control. CV Positive Control and No-Template Control are included. Purified RNA from upper or lower respiratory samples is added directly to the reagent. It runs on real-time instruments that read HEX/VIC and Quasar 670/Cy5, supports automated setup, and is sold in 100-, 1,000- and 10,000-reaction sizes. Add it to your LIGHT LABS order and keep your bench stocked.
Key Features
- Multiplex format – viral N gene and human RNase P targets are detected together.
- High sensitivity – limit of detection as low as 10 viral genome copies per reaction.
- Rapid results – turnaround in less than two hours.
- Controls included – CV Positive Control and No-Template Control support run validation.
- Automation compatible – simple setup suits high-throughput platforms.
Specifications
| Catalog Number | R3013 |
| Brand | Zymo Research |
| Description | Quick SARS-CoV-2 Multiplex Kit, 100 Rxns |
| Method | Multiplex real-time reverse transcription PCR (qualitative) |
| Targets | SARS-CoV-2 N gene region; human RNase P |
| Limit of detection | As low as 10 viral genome equivalent copies per reaction |
| Turnaround time | Less than 2 hours |
| Detection channels | HEX/VIC and Quasar 670/Cy5 |
| Sample input | Purified RNA from upper and lower respiratory samples |
| Kit sizes | 100, 1,000 or 10,000 reactions |
| Shipping Conditions | Ships on dry ice |
| Storage | -80°C |
Available Sizes & Components
- R3013-10K – Quick SARS-CoV-2 Multiplex Kit, 10,000 Rxns
- R3013-1K – Quick SARS-CoV-2 Multiplex Kit, 1000 Rxns
Applications
- SARS-CoV-2 RNA detection
- Respiratory specimen testing
- High-throughput screening
- Viral surveillance
